Improving life after brain injury Need to talk? 0808 800 2244

Home News and campaigns News Media centre Headway in the news

Headway’s comment on T...

Headway’s comment on TXA drug featured by The Times Main Image

Headway’s comment on TXA drug featured by The Times

Wed 23 Oct 2019

The Times has featured Headway’s comments on the findings of a new study which looked into the benefits of Tranexamic Acid (TXA).

The findings revealed that the TXA drug can reduce the risk of death for those who suffer a mild or moderate traumatic brain injury.

Peter McCabe, Chief Executive of Headway, said: “Every three minutes someone in the UK is admitted to hospital with a head injury so it is encouraging to hear the findings of this study and the potential for TXA to help people.

“While this study does not demonstrate lives will be saved following severe brain injury, we know that patients with mild to moderate brain injuries can suffer complications where TXA may be beneficial.

“It’s also important to recognise that improvements in acute care have to be match by investment in rehabilitation. Put simply, a life worth saving has to be a life worth living.”


Share this page

Headway - the brain injury association is registered with the Charity Commission for England and Wales (Charity no. 1025852) and the Office of the Scottish Regulator (Charity no. SC 039992). Headway is a company limited by guarantee, registered in England no. 2346893.

© Copyright Headway 2024  -  Site designed and developed by MEDIAmaker